应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LIAN 联拓生物
退市 07-23 16:00:00 EDT
0.3190
+0.0000
0.00%
最高
0.3190
最低
0.3190
成交量
0.00
今开
0.3190
昨收
0.3190
日振幅
0.00%
总市值
3,450万
流通市值
810.52万
总股本
1.08亿
成交额
0.00
换手率
0.00%
流通股本
2,541万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
联拓生物盘中异动 股价大跌8.02%
自选股智能写手 · 03-18
联拓生物盘中异动 股价大跌8.02%
联拓生物股价上涨13.00% 市值涨419.56万美元
自选股智能写手 · 03-15
联拓生物股价上涨13.00% 市值涨419.56万美元
联拓生物决定自愿从美国纳斯达克退市以减轻运营负担
金融界 · 02-29
联拓生物决定自愿从美国纳斯达克退市以减轻运营负担
联拓生物(LIAN.US)自愿从纳斯达克退市 预计将在OTC市场交易
智通财经 · 02-28
联拓生物(LIAN.US)自愿从纳斯达克退市 预计将在OTC市场交易
2024年首家!明星Biotech联拓生物宣布退市 曾高调拒绝“卖身”
华夏时报 · 02-19
2024年首家!明星Biotech联拓生物宣布退市 曾高调拒绝“卖身”
明星biotech落幕,“伪license in”时代的彻底终结
钛媒体APP · 02-19
明星biotech落幕,“伪license in”时代的彻底终结
联拓生物将裁员并退市:派发股息超5亿美元 CEO王轶喆离职
雷递网 · 02-19
联拓生物将裁员并退市:派发股息超5亿美元 CEO王轶喆离职
Biotech行业寒冬下 联拓生物官宣“关门”、退市
蓝鲸财经 · 02-18
Biotech行业寒冬下 联拓生物官宣“关门”、退市
联拓生物官宣关停背后:License-in模式遇冷下Biotech出路何在?
21世纪经济报道 · 02-18
联拓生物官宣关停背后:License-in模式遇冷下Biotech出路何在?
关门!退市!联拓生物(LIAN.US)等一批Biotech在消亡
智通财经网 · 02-14
关门!退市!联拓生物(LIAN.US)等一批Biotech在消亡
曾拒绝被收购,如今联拓生物将关闭业务并退市
第一财经 · 02-14
曾拒绝被收购,如今联拓生物将关闭业务并退市
嗡嗡声--美国股票走势-捷蓝航空公司、LPL Financial、Nvidia
Reuters · 02-14
嗡嗡声--美国股票走势-捷蓝航空公司、LPL Financial、Nvidia
联拓生物盘中异动 早盘急速拉升20.46%
自选股智能写手 · 02-13
联拓生物盘中异动 早盘急速拉升20.46%
BUZZ-联建生物完成战略审查,裁员;股价上涨
Reuters · 02-13
BUZZ-联建生物完成战略审查,裁员;股价上涨
睿智医药(300149.SZ)选举WOO SWEE LIAN为董事长
智通财经 · 01-10
睿智医药(300149.SZ)选举WOO SWEE LIAN为董事长
联拓生物盘中异动 早盘股价大跌5.69%报4.31美元
自选股智能写手 · 2023-12-27
联拓生物盘中异动 早盘股价大跌5.69%报4.31美元
联拓生物盘中异动 股价大涨5.33%
自选股智能写手 · 2023-12-27
联拓生物盘中异动 股价大涨5.33%
联拓生物(LIAN.US)盘前一度涨超10% 将NBTXR3在华市场权利转让至杨森
智通财经 · 2023-12-26
联拓生物(LIAN.US)盘前一度涨超10% 将NBTXR3在华市场权利转让至杨森
联拓生物签署协议转让其在中国及其他亚洲市场对NBTXR3的权利
GlobeNewswire · 2023-12-26
联拓生物签署协议转让其在中国及其他亚洲市场对NBTXR3的权利
联拓生物盘中异动 早盘大幅下跌5.00%
自选股智能写手 · 2023-12-22
联拓生物盘中异动 早盘大幅下跌5.00%
加载更多
公司概况
公司名称:
联拓生物
所属市场:
NASDAQ
上市日期:
--
主营业务:
LianBio于2019年7月17日在开曼群岛注册成立。该公司是一家全球性的、以科学为导向的生物制药公司,致力于为未满足医疗需求的患者开发和商业化创新药物,最初专注于大中华区和其他亚洲市场的授权资产。该公司有目的地设计了他们的组织,通过识别、采购、开发和商业化候选产品以及与世界各地高度创新的生物制药公司合作,成功地执行他们的愿景。该公司正在建立一个国际基础设施,将他们自己定位为首选合作伙伴,并提供一个平台,以提供进入其目标市场的机会。
发行价格:
--
{"stockData":{"symbol":"LIAN","market":"US","secType":"STK","nameCN":"联拓生物","latestPrice":0.319,"timestamp":1721764800000,"preClose":0.319,"halted":4,"volume":0,"delay":0,"floatShares":25408205,"shares":108165130,"eps":-0.819144,"marketStatus":"退市","marketStatusCode":5,"change":0,"latestTime":"07-23 16:00:00 EDT","open":0.319,"high":0.319,"low":0.319,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.819144,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721808000000},"adr":0,"listingDate":1635739200000,"adjPreClose":0.319,"adrRate":1,"volumeRatio":0},"requestUrl":"/m/hq/s/LIAN","defaultTab":"news","newsList":[{"id":"2420474592","title":"联拓生物盘中异动 股价大跌8.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420474592","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420474592?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:32","pubTimestamp":1710768720,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时32分,联拓生物股票出现异动,股价快速跳水8.02%。截至发稿,该股报0.320美元/股,成交量27.2625万股,换手率0.25%,振幅4.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。联拓生物股票所在的生物技术行业中,整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182132008b434d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182132008b434d4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2419974561","title":"联拓生物股价上涨13.00% 市值涨419.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974561","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419974561?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:30","pubTimestamp":1710509446,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时30分,联拓生物股票出现异动,股价快速上涨13.00%。截至发稿,该股报0.271美元/股,成交量771.107万股,换手率7.14%,振幅1.17%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。联拓生物股票所在的生物技术行业中,整体涨幅为0.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213046861dea93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213046861dea93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2415034003","title":"联拓生物决定自愿从美国纳斯达克退市以减轻运营负担","url":"https://stock-news.laohu8.com/highlight/detail?id=2415034003","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415034003?lang=zh_cn&edition=full","pubTime":"2024-02-29 01:36","pubTimestamp":1709141785,"startTime":"0","endTime":"0","summary":"联拓生物计将于2024年3月11日左右向美国证券交易委员会和纳斯达克提交关于其美国存托凭证自愿退市的表格。这一决定意味着,在退市之后,联拓生物的ADS将不再在纳斯达克公开交易,而只能通过私下协商的方式进行交易,可能会转至场外交易市场。联拓生物此前已透露,在董事会完成对公司的全面战略评估后,公司已开始逐步关闭其业务,包括公司普通股和美国存托凭证的自愿退市和注销。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022901404287cd82b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022901404287cd82b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NQmain","BK4007","QQQ","LIAN","QID","TQQQ","QLD","MNQmain","SQQQ","NDX","ARTL",".IXIC","BK4139","PSQ"],"gpt_icon":0},{"id":"2414323543","title":"联拓生物(LIAN.US)自愿从纳斯达克退市 预计将在OTC市场交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2414323543","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414323543?lang=zh_cn&edition=full","pubTime":"2024-02-28 20:38","pubTimestamp":1709123933,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,联拓生物(LIAN.US)2月28日宣布,已向纳斯达克交易所发出通知,其打算将公司的美股ADS从纳斯达克全球市场(Nasdaq Global Market)摘牌。联拓生物在一份声明中表示,预计将于2024年3月11日前后向美国证券交易委员会(SEC)和纳斯达克提交一份有关其ADS自愿退市的Form 25。该公司预计其ADS将在OTC Markets Group运营的市场上进行报价,以便其ADS的交易市场可以继续存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1078544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QLD","PSQ","BK4139","BK4007","QID","MNQmain","LIAN","SQQQ","03086","TQQQ","QQQ","NDX","NQmain","ARTL",".IXIC","BK1147"],"gpt_icon":0},{"id":"2412792134","title":"2024年首家!明星Biotech联拓生物宣布退市 曾高调拒绝“卖身”","url":"https://stock-news.laohu8.com/highlight/detail?id=2412792134","media":"华夏时报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412792134?lang=zh_cn&edition=full","pubTime":"2024-02-19 23:15","pubTimestamp":1708355754,"startTime":"0","endTime":"0","summary":"2月13日,联拓生物宣布公司董事会已完成对公司的全面战略审查,决定开始关闭业务,随后将出售剩余管线资产,并且从纳斯达克退市。联拓生物预计,公司将在2027年上半年完全解散。这也成为2024年首家关停的Biotech企业。联拓生物将有权获得总计3.5亿美元的对价。记者梳理发现,2023年,已有不少Biotech企业选择关停卖厂。同时,Biotech企业还需要对未来的市场环境保持警惕,及时调整战略,以适应不断变化的市场和行业环境。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219231641819caddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219231641819caddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2412797142","title":"明星biotech落幕,“伪license in”时代的彻底终结","url":"https://stock-news.laohu8.com/highlight/detail?id=2412797142","media":"钛媒体APP","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412797142?lang=zh_cn&edition=full","pubTime":"2024-02-19 13:57","pubTimestamp":1708322246,"startTime":"0","endTime":"0","summary":"尽管去年以来,license in极速降温,但有钱又有项目的联拓生物,一步步走到今天,仍令人唏嘘不已。而如今,在out交易成为主流的同时,license in的重要性也不会消失。只不过,那些“伪license in”彻底失去了生存的土壤。在此之前,国内已经有biotech依靠license in模式快速发展。当然,biotech各方面所面临的挑战也极大。尤其是对于走license in道路的联拓生物来说。License in更多是轻研究、重BD、更重临床开发,目的是加速药物上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021914003087a044f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021914003087a044f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2412706942","title":"联拓生物将裁员并退市:派发股息超5亿美元 CEO王轶喆离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2412706942","media":"雷递网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412706942?lang=zh_cn&edition=full","pubTime":"2024-02-19 09:04","pubTimestamp":1708304652,"startTime":"0","endTime":"0","summary":"但这一收购要约遭遇联拓生物董事会的拒绝。2021年11月,联拓生物纳斯达克上市,募资3.2亿美元。联拓生物上市首日下跌14.38%;以收盘价计算,联拓生物市值为14.42亿美元。根据协议条款,联拓有权获得总计3.5亿美元的对价。根据协议条款,联拓生物一次性收到2500万美元的付款。此外,联拓生物还有资格获得500万美元的销售里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219090427819a7244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219090427819a7244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2412806991","title":"Biotech行业寒冬下 联拓生物官宣“关门”、退市","url":"https://stock-news.laohu8.com/highlight/detail?id=2412806991","media":"蓝鲸财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412806991?lang=zh_cn&edition=full","pubTime":"2024-02-18 22:33","pubTimestamp":1708266785,"startTime":"0","endTime":"0","summary":"在经历了出售管线、高管离任、拒绝收购等一系列事件后,联拓生物最终选择了“关门”、退市。自2022年起,Biotech行业持续陷入寒冬,至2023年,寒风仍然未能消散。在融资难题和现金流压力之下,行业内企业也在经历着自救与出清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202402182987768661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2412993592","title":"联拓生物官宣关停背后:License-in模式遇冷下Biotech出路何在?","url":"https://stock-news.laohu8.com/highlight/detail?id=2412993592","media":"21世纪经济报道","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412993592?lang=zh_cn&edition=full","pubTime":"2024-02-18 20:23","pubTimestamp":1708259019,"startTime":"0","endTime":"0","summary":"近日,曾经的License-in模式代表企业联拓生物宣布,公司董事会已完成对公司的全面战略审查,并决定开始逐步缩减其业务。包括出售剩余资产、裁员、从纳斯达克退市和逐步停止其临床试验,同时决定发放4.8美元/股的特别股息,总计金额约5.28亿美元。联拓生物预计将于2024年底前完成其终止运营的相关活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202402182987735585.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202402182987735585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2411065333","title":"关门!退市!联拓生物(LIAN.US)等一批Biotech在消亡","url":"https://stock-news.laohu8.com/highlight/detail?id=2411065333","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411065333?lang=zh_cn&edition=full","pubTime":"2024-02-14 20:42","pubTimestamp":1707914520,"startTime":"0","endTime":"0","summary":"2024年,达摩克利斯之剑开始逐一落到中国Biotech的头上。换句话说,这家成立不到5年、走“License-in”商业模式的本土Biotech,关门在即。2023年,当诸多秘而不宣的事情陆续被曝光,行业意识到已有不少Biotech被裹挟其中。去年底,联拓生物CEO和CFO相继出走,同月拒绝了Concentra Biosciences的收购邀约。不到3个月,联拓生物宣布“关门”,令人唏嘘。不过自去年以来,联拓生物、博际生物并非第一批“消失”的Biotech,水面之下,还有一片冰山。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-02-14/doc-inahziah0801260.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-02-14/doc-inahziah0801260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2411171379","title":"曾拒绝被收购,如今联拓生物将关闭业务并退市","url":"https://stock-news.laohu8.com/highlight/detail?id=2411171379","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411171379?lang=zh_cn&edition=full","pubTime":"2024-02-14 18:07","pubTimestamp":1707905220,"startTime":"0","endTime":"0","summary":"前期拒绝了concentra要约收购的联拓生物,如今转身决定要直接关闭业务和退市。2月13日,联拓生物宣布公司董事会已完成对公司的全面战略审查,并决定开始关闭业务,随后将出售剩余管线资产,并且从纳斯达克退市。联拓生物将有权获得总计3.5亿美元的对价。联拓生物预计,公司将在2024年基本完成全面关闭业务,在2027年上半年完全解散。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402141808087a439d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402141808087a439d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2411839396","title":"嗡嗡声--美国股票走势-捷蓝航空公司、LPL Financial、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2411839396","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411839396?lang=zh_cn&edition=full","pubTime":"2024-02-14 03:25","pubTimestamp":1707852333,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月13日 - 华尔街主要股指周二下滑,触及一周低点,此前消费者通胀数据高于预期,推动美国国债收益率走高,令市场对即将降息的猜测打消。美东时间13:36,道琼斯工业平均指数 报38,133.46点,上涨1.71%。标准普尔500指数 下跌1.36%,报4,953.74点;纳斯达克综合指数 下跌1.68%,报15,675.194点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DDM","PSQ","MNQmain","NEM","CDNS","LIAN","VGAS","HAS","HUT","BCYC","CMA",".SPX","TRU","EXPR","HWM","RENB","CADL","DNUT","BHF","KLG","NQmain","USB","LDOS","NVDA","BIIB","GTES","ECL",".DJI","PARA","MAR","RIOT","SQQQ","TRIP","LPL","ANET",".IXIC","BMR","NYCB","XAIR","JPM","COIN","GFS","TAP","KALV","JBLU","MCO","LSCC","ALT","ZTS","DOG"],"gpt_icon":0},{"id":"2411350726","title":"联拓生物盘中异动 早盘急速拉升20.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411350726","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411350726?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:33","pubTimestamp":1707834821,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时33分,联拓生物股票出现异动,股价快速拉升20.46%。截至发稿,该股报4.87美元/股,成交量295.434万股,换手率2.73%,振幅3.22%。联拓生物股票所在的生物技术行业中,整体跌幅为0.79%。其相关个股中,Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、联拓生物涨幅较大,Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃,换手率分别为299.60%、84.60%、34.11%,振幅较大的相关个股有Kalvista Pharmaceuticals Inc、Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc,振幅分别为12.47%、12.41%、12.38%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213223341878d17e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213223341878d17e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2411350385","title":"BUZZ-联建生物完成战略审查,裁员;股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2411350385","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411350385?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:32","pubTimestamp":1707834772,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 2月13日 - ** 生物技术公司LianBio 早盘股价上涨18.8%至4.80美元** 该公司称已完成战略审查,并计划启动业务收尾,包括出售在研药物** LIAN预计将在2024年底前完成收尾工作** 预计2024年第一季度将减少50多名全职员工,约占现有员工总数的50** 表示预计在 2027 年上半年完全解散** 截至上次收盘,股价在过去 12 个月中上涨了约 89","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","LIAN"],"gpt_icon":0},{"id":"2402761741","title":"睿智医药(300149.SZ)选举WOO SWEE LIAN为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2402761741","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2402761741?lang=zh_cn&edition=full","pubTime":"2024-01-10 18:36","pubTimestamp":1704883019,"startTime":"0","endTime":"0","summary":"智通财经APP讯,睿智医药(300149.SZ)公告,公司董事会审议通过了《关于选举第五届董事会董事长的议案》,同意选举WOO SWEE LIAN为公司第五届董事会董事长,任期自本次董事会审议通过之日起至第五届董事会届满之日止。公司法定代表人将同步变更为WOO SWEE LIAN先生。此外,董事会同意聘任WOO SWEE LIAN先生为公司首席执行官(CEO),任期自本次董事会审议通过之日起至第五届董事会届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1053150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2394396907","title":"联拓生物盘中异动 早盘股价大跌5.69%报4.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2394396907","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2394396907?lang=zh_cn&edition=full","pubTime":"2023-12-27 22:30","pubTimestamp":1703687432,"startTime":"0","endTime":"0","summary":"北京时间2023年12月27日22时30分,联拓生物股票出现波动,股价快速跳水5.69%。截至发稿,该股报4.31美元/股,成交量1.6993万股,换手率0.02%,振幅1.86%。联拓生物股票所在的生物技术行业中,整体涨幅为0.50%。其相关个股中,First Wave Biopharma Inc、Cingulate Inc、Cytokinetics Inc涨幅较大,First Wave Biopharma Inc、Cingulate Inc、Hoth Therapeutics Inc较为活跃,换手率分别为1011.61%、981.51%、56.71%,振幅较大的相关个股有Nkgen Biotech Inc、First Wave Biopharma Inc、Quince Therapeutics Inc,振幅分别为6.15%、5.34%、4.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122722303287e61f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122722303287e61f1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2394223278","title":"联拓生物盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2394223278","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2394223278?lang=zh_cn&edition=full","pubTime":"2023-12-27 01:14","pubTimestamp":1703610883,"startTime":"0","endTime":"0","summary":"北京时间2023年12月27日01时14分,联拓生物股票出现异动,股价急速上涨5.33%。截至发稿,该股报4.74美元/股,成交量33.6012万股,换手率0.31%,振幅4.44%。机构评级方面,在所有3家参与评级的机构中,33%的券商给予买入建议,67%的券商给予持有建议,无券商给予卖出建议。联拓生物股票所在的生物技术行业中,整体涨幅为0.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312270114437a3646d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312270114437a3646d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2394243861","title":"联拓生物(LIAN.US)盘前一度涨超10% 将NBTXR3在华市场权利转让至杨森","url":"https://stock-news.laohu8.com/highlight/detail?id=2394243861","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2394243861?lang=zh_cn&edition=full","pubTime":"2023-12-26 19:18","pubTimestamp":1703589505,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,联拓生物已经与强生子公司杨森制药签署了一项重要协议,转让该公司在中国和其他亚洲市场的研究性放射增强剂NBTXR3的权利。根据协议条款,联拓生物已将其在中国、韩国、新加坡和泰国开发和商业化NBTXR3的独家权利授予美国医药巨头强生旗下的杨森。据了解,早在2021年5月,联拓生物从Nanobiotix获得了NBTXR3在中国市场、泰国、韩国以及新加坡市场进行推广和商业化的许可权利。在这一最新消息传出后,联拓生物盘前一度涨超10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1045399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2394121542","title":"联拓生物签署协议转让其在中国及其他亚洲市场对NBTXR3的权利","url":"https://stock-news.laohu8.com/highlight/detail?id=2394121542","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2394121542?lang=zh_cn&edition=full","pubTime":"2023-12-26 07:00","pubTimestamp":1703545200,"startTime":"0","endTime":"0","summary":"根据协议条款,联拓生物将一次性收到2500万美元的付款。关于联拓生物 联拓生物是一家跨国生物技术公司,其使命是为中国和亚洲患者带来颠覆性药物。联拓生物正在建立国际化的基础设施,从而将公司定位为首选的合作对象,并为合作伙伴提供进入中国和其他亚洲市场的平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2023/12/26/2801028/0/zh-hans/%E8%81%94%E6%8B%93%E7%94%9F%E7%89%A9%E7%AD%BE%E7%BD%B2%E5%8D%8F%E8%AE%AE%E8%BD%AC%E8%AE%A9%E5%85%B6%E5%9C%A8%E4%B8%AD%E5%9B%BD%E5%8F%8A%E5%85%B6%E4%BB%96%E4%BA%9A%E6%B4%B2%E5%B8%82%E5%9C%BA%E5%AF%B9NBTXR3%E7%9A%84%E6%9D%83%E5%88%A9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2393974490","title":"联拓生物盘中异动 早盘大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393974490","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2393974490?lang=zh_cn&edition=full","pubTime":"2023-12-22 22:30","pubTimestamp":1703255433,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日22时30分,联拓生物股票出现波动,股价急速下挫5.00%。截至发稿,该股报4.37美元/股,成交量1.2437万股,换手率0.01%,振幅0.00%。联拓生物股票所在的生物技术行业中,整体涨幅为0.00%。高层人事变动引发外界对联拓生物团队稳定性的质疑。2021年11月,联拓生物在美国纳斯达克上市。在此次人事变动之前,12月1日,联拓生物收到了一份收购提案。目前,联拓生物尚无一款产品上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122222303579031427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122222303579031427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lianbio.com;www.lianbiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.922},{"period":"1year","weight":-0.857},{"period":"ytd","weight":-0.9286}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LianBio于2019年7月17日在开曼群岛注册成立。该公司是一家全球性的、以科学为导向的生物制药公司,致力于为未满足医疗需求的患者开发和商业化创新药物,最初专注于大中华区和其他亚洲市场的授权资产。该公司有目的地设计了他们的组织,通过识别、采购、开发和商业化候选产品以及与世界各地高度创新的生物制药公司合作,成功地执行他们的愿景。该公司正在建立一个国际基础设施,将他们自己定位为首选合作伙伴,并提供一个平台,以提供进入其目标市场的机会。","exchange":"NASDAQ","name":"联拓生物","nameEN":"LianBio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联拓生物(LIAN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联拓生物(LIAN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联拓生物,LIAN,联拓生物股票,联拓生物股票老虎,联拓生物股票老虎国际,联拓生物行情,联拓生物股票行情,联拓生物股价,联拓生物股市,联拓生物股票价格,联拓生物股票交易,联拓生物股票购买,联拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联拓生物(LIAN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联拓生物(LIAN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}